col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


73 Results       Page 1

 [1] 
Elsevier: International Journal of Biological Macromolecules
  original article Date Title Authors   All Authors
1 [GO] 2022―Apr―23 Designing and characterization of a SARS-CoV-2 immunogen with receptor binding motif grafted on a protein scaffold: An epitope-focused vaccine approach Ritika Khatri, Hilal Ahmad Parray, Ashish Kumar Agrahari, Zaigham Abbas Rizvi, Rachel Kaul, Sneha Raj, et al. (+5)
2 [GO] 2022―Apr―20 Isolation, characterization, and structure-based engineering of a neutralizing nanobody against SARS-CoV-2 Tingting Li, Bingjie Zhou, Yaning Li, Suqiong Huang, Zhipu Luo, Yuanze Zhou, et al. (+8)
3 [GO] 2022―Apr―19 Expression, purification, and biophysical characterization of recombinant MERS-CoV main (Mpro) protease Ghada Obeid Almutairi, Ajamaluddin Malik, Mona Alonazi, Javed Masood Khan, Abdullah S. Alhomida, Mohd Shahnawaz Khan, et al. (+3)
4 [GO] 2022―Mar―26 Interfering effects on the bioactivities of several key proteins of COVID-19/variants in diabetes by compounds from Lianqiao leaves: In silico and in vitro analyses Yishan Fu, Fei Pan, Lei Zhao, Shuai Zhao, Junjie Yi, Shengbao Cai
5 [GO] 2022―Mar―16 An insight to the therapeutic potential of algae-derived sulfated polysaccharides and polyunsaturated fatty acids: Focusing on the COVID-19 Kobra Ziyaei, Zahra Ataie, Majid Mokhtari, Kelvin Adrah, Mohammad Ali Daneshmehr
6 [GO] 2022―Mar―15 The spike glycoproteins of SARS-CoV-2: A review of how mutations of spike glycoproteins have driven the emergence of variants with high transmissibility and immune escape Pedro F.N. Souza, Felipe P. Mesquita, Jackson L. Amaral, Patrícia G.C. Landim, Karollyny R.P. Lima, Marília B. Costa, et al. (+8)
7 [GO] 2022―Feb―08 Human SARS-CoV-2 has evolved to increase U content and reduce genome size Yong Wang, Xin-Yu Chen, Liu Yang, Qin Yao, K.P. Chen
8 [GO] 2022―Jan―22 Three wave changes, new variant strains, and vaccination effect against COVID-19 pandemic Rehan M. El-Shabasy, Mohamed A. Nayel, Mohamed M. Taher, Rehab Abdelmonem, Kamel R. Shoueir, El Refaie Kenawy
9 [GO] 2022―Jan―22 Insights into the specificity for the interaction of the promiscuous SARS-CoV-2 nucleocapsid protein N-terminal domain with deoxyribonucleic acids Icaro Putinhon Caruso, Vitor dos Santos Almeida, Mariana Juliani do Amaral, Guilherme Caldas de Andrade, Gabriela Rocha de Araújo, Talita Stelling de Araújo, et al. (+21)
10 [GO] 2022―Jan―20 Review: A systematic review of virus-like particles of coronavirus: Assembly, generation, chimerism and their application in basic research and in the clinic Wan Lu, Zhuangzhuang Zhao, Yao-Wei Huang, Bin Wang
11 [GO] 2022―Jan―19 The Omicron (B.1.1.529) variant of SARS-CoV-2 binds to the hACE2 receptor more strongly and escapes the antibody response: Insights from structural and simulation data Abbas Khan, Hira Waris, Memoona Rafique, Muhammad Suleman, Anwar Mohammad, Syed Shujait Ali, et al. (+4)
12 [GO] 2022―Jan―17 Dimerization of SARS-CoV-2 nucleocapsid protein affects sensitivity of ELISA based diagnostics of COVID-19 Wajihul Hasan Khan, Nida Khan, Avinash Mishra, Surbhi Gupta, Vikrant Bansode, Deepa Mehta, et al. (+4)
13 [GO] 2021―Dec―28 Silymarin/curcumin loaded albumin nanoparticles coated by chitosan as muco-inhalable delivery system observing anti-inflammatory and anti COVID-19 characterizations in oleic acid triggered lung injury and in vitro COVID-19 experiment Nemany A.N. Hanafy, Maged A. El-Kemary
14 [GO] 2021―Dec―23 Is amyloid fibrillation related to 3D domain swapping for the C-terminal domain of SARS-CoV main protease? Zhiliang Yuan, Zhi Qu, Bo Duan, Tianyi Wang, Jiajun Xu, Bin Xia
15 [GO] 2021―Dec―04 Precise location of two novel linear epitopes on the receptor-binding domain surface of MERS-CoV spike protein recognized by two different monoclonal antibodies Pan Wang, Peiyang Ding, Qiang Wei, Aiping Wang, Hongliang Liu, Yunchao Liu, et al. (+5)
16 [GO] 2021―Dec―02 Emergence of unique SARS-CoV-2 ORF10 variants and their impact on protein structure and function Sk. Sarif Hassan, Kenneth Lundstrom, Ángel Serrano-Aroca, Parise Adadi, Alaa A.A. Aljabali, Elrashdy M. Redwan, et al. (+13)
17 [GO] 2021―Nov―24 Identifying potential novel insights for COVID-19 pathogenesis and therapeutics using an integrated bioinformatics analysis of host transcriptome Salem A. El-aarag, Amal Mahmoud, Mahmoud ElHefnawi
18 [GO] 2021―Nov―12 COVID-19 diagnosis: current and future techniques Aarjoo Sharma, Sanjeev Balda, Mansi Apreja, Kirti Kataria, Neena Capalash, Prince Sharma
19 [GO] 2021―Nov―11 Nanoparticular CpG-adjuvanted SARS-CoV-2 S1 protein elicits broadly neutralizing and Th1-biased immunoreactivity in mice Hui-Tsu Lin, Cheng-cheung Chen, Der-Jiang Chiao, Tein-Yao Chang, Xin-an Chen, Jenn-jong Young, Szu-Cheng Kuo
20 [GO] 2021―Nov―11 Structural and functional significance of the amino acid differences Val35Thr, Ser46Ala, Asn65Ser, and Ala94Ser in 3C-like proteinases from SARS-CoV-2 and SARS-CoV Alexander I. Denesyuk, Eugene A. Permyakov, Mark S. Johnson, Sergei E. Permyakov, Konstantin Denessiouk, Vladimir N. Uversky
21 [GO] 2021―Oct―31 Immunology and controlling of coronaviruses; the current enemy for humanity: A review Sarah I. Othman, Mohamed A. Nayel, Maha Abdulla Alwaele, Haifa Al Fassam, Gasem Mohammad Abu-Taweel, Naif Ghazi Altoom, et al. (+4)
22 [GO] 2021―Oct―29 SARS-CoV-2 spike protein causes blood coagulation and thrombosis by competitive binding to heparan sulfate Yi Zheng, Jinxiang Zhao, Jiaqi Li, Zhimou Guo, Jiajing Sheng, Xianlong Ye, et al. (+6)
23 [GO] 2021―Oct―28 SARS-COV-2, infection, transmission, transcription, translation, proteins, and treatment: A review Jahangir Emrani, Maryam Ahmed, Robert H. Newman, Misty D. Thomas, Nathan Mowa, Liesl JeffersFrancis, John C. Teleha
24 [GO] 2021―Oct―25 COVID-19: A review of newly formed viral clades, pathophysiology, therapeutic strategies and current vaccination tasks Chandran Murugan, Sharmiladevi Ramamoorthy, Kuppuswamy Guruprasad, Rajesh Kumar Murugan, Yuvaraj Sivalingam, Anandhakumar Sundaramurthy
25 [GO] 2021―Oct―18 Review: Roles of human serum albumin in prediction, diagnoses and treatment of COVID-19 Gulam Rabbani, Saeyoung Nate Ahn
26 [GO] 2021―Oct―15 State-of-the-art review - A review on snake venom-derived antithrombotics: Potential therapeutics for COVID-19-associated thrombosis? Bhargab Kalita, Anthony J. Saviola, Stephen P. Samuel, Ashis K. Mukherjee
27 [GO] 2021―Sep―27 Spike protein recognizer receptor ACE2 targeted identification of potential natural antiviral drug candidates against SARS-CoV-2 Sushil Pokhrel, Thamer A. Bouback, Abdus Samad, Suza Mohammad Nur, Rahat Alam, Md. Abdullah-Al-Mamun, et al. (+9)
28 [GO] 2021―Sep―24 Implications derived from S-protein variants of SARS-CoV-2 from six continents Sk. Sarif Hassan, Kenneth Lundstrom, Debmalya Barh, Raner Jośe Santana Silva, Bruno Silva Andrade, Vasco Azevedo, et al. (+18)
29 [GO] 2021―Sep―10 Genomics-guided targeting of stress granule proteins G3BP1/2 to inhibit SARS-CoV-2 propagation Nemat Ali, Kartikay Prasad, Abdullah F. AlAsmari, Metab Alharbi, Summya Rashid, Vijay Kumar
30 [GO] 2021―Sep―07 Mucosal IgA response elicited by intranasal immunization of Lactobacillus plantarum expressing surface-displayed RBD protein of SARS-CoV-2 Letian Li, Maopeng Wang, Jiayi Hao, Jicheng Han, Tingting Fu, Jieying Bai, et al. (+4)
31 [GO] 2021―Aug―18 Review on oxidative stress relation on COVID-19: Biomolecular and bioanalytical approach Mehrnaz Ebrahimi, Parviz Norouzi, Hossein Aazami, Ali Akbar Moosavi-Movahedi
32 [GO] 2021―Aug―14 SARS-CoV-2 (Covid-19) vaccines structure, mechanisms and effectiveness: A review Hadis Fathizadeh, Saman Afshar, Mahmood Reza Masoudi, Pourya Gholizadeh, Mohammad Asgharzadeh, Khudaverdi Ganbarov, et al. (+3)
33 [GO] 2021―Aug―06 Repurposing clinically approved drugs for COVID-19 treatment targeting SARS-CoV-2 papain-like protease Yunxia Xu, Ke Chen, Juanli Pan, Yingshou Lei, Danting Zhang, Lipei Fang, et al. (+8)
34 [GO] 2021―Aug―06 The method utilized to purify the SARS-CoV-2 N protein can affect its molecular properties Aneta Tarczewska, Marta Kolonko-Adamska, Mirosław Zarębski, Jurek Dobrucki, Andrzej Ożyhar, Beata Greb-Markiewicz
35 [GO] 2021―Jul―30 Flavonoids in Ampelopsis grossedentata as covalent inhibitors of SARS-CoV-2 3CLpro: Inhibition potentials, covalent binding sites and inhibitory mechanisms Yuan Xiong, Guang-Hao Zhu, Ya-Ni Zhang, Qing Hu, Hao-Nan Wang, Hao-Nan Yu, et al. (+5)
36 [GO] 2021―Jul―27 Chitosan derivatives: A suggestive evaluation for novel inhibitor discovery against wild type and variants of SARS-CoV-2 virus Chandrima Modak, Anubhuti Jha, Nivya Sharma, Awanish Kumar
37 [GO] 2021―Jul―05 Treatment and prevention strategies for the COVID 19 pandemic: A review of immunotherapeutic approaches for neutralizing SARS-CoV-2 Pravas Kumar Baral, Jiang Yin, Michael N.G. James
38 [GO] 2021―Jun―07 A potential antiviral activity of Esculentoside A against binding interactions of SARS-COV-2 spike protein and angiotensin converting enzyme 2 (ACE2) Mao-Sen Zeng, Wen-Di Yu, Hui-Xian Wang, Jin-Yuan Liu, Pei-Ping Xu
39 [GO] 2021―May―26 Ethyl cellulose coated sustained release aspirin spherules for treating COVID-19: DOE led rapid optimization using arbitrary interface; applicable for emergency situations T. Sreejith, Kaladhar Kamalasanan, Ashna Moidu, Pooja Shyamsundar, Shanti V. Nair, Lakshmi J. Nair, P. Venkatesan
40 [GO] 2021―May―25 Chitosan, alginate, hyaluronic acid, gums, and β-glucan as potent adjuvants and vaccine delivery systems for viral threats including SARS-CoV-2: A review Shadpour Mallakpour, Elham Azadi, Chaudhery Mustansar Hussain
41 [GO] 2021―Apr―27 Chitin and chitosan as tools to combat COVID-19: A triple approach Mehrnoush Safarzadeh, Sahar Sadeghi, Mahdieh Azizi, Mohsen Rastegari-Pouyani, Ramin Pouriran, Mostafa Haji Molla Hoseini
42 [GO] 2021―Apr―26 Heparin: A simplistic repurposing to prevent SARS-CoV-2 transmission in light of its in-vitro nanomolar efficacy Yash Gupta, Dawid Maciorowski, Samantha E. Zak, Chandrashekhar V. Kulkarni, Andrew S. Herbert, Ravi Durvasula, et al. (+3)
43 [GO] 2021―Apr―24 Identification of Vitamin K3 and its analogues as covalent inhibitors of SARS-CoV-2 3CLpro Ruyu Wang, Qing Hu, Haonan Wang, Guanghao Zhu, Mengge Wang, Qian Zhang, et al. (+6)
44 [GO] 2021―Apr―21 Preparation of cellulose based wipes treated with antimicrobial and antiviral silver nanoparticles as novel effective high-performance coronavirus fighter Tamer Hamouda, Hassan M. Ibrahim, H.H. Kafafy, H.M. Mashaly, Nasser H. Mohamed, Nermin M. Aly
45 [GO] 2021―Apr―16 Notable sequence homology of the ORF10 protein introspects the architecture of SARS-CoV-2 Sk. Sarif Hassan, Diksha Attrish, Shinjini Ghosh, Pabitra Pal Choudhury, Vladimir N. Uversky, Alaa A.A. Aljabali, et al. (+19)
46 [GO] 2021―Mar―29 A review on antiviral and immunomodulatory polysaccharides from Indian medicinal plants, which may be beneficial to COVID-19 infected patients Ipsita Kumar Sen, Indranil Chakraborty, Amit Kumar Mandal, Sunil Kumar Bhanja, Sukesh Patra, Prasenjit Maity
47 [GO] 2021―Mar―23 A review on the interaction of nucleoside analogues with SARS-CoV-2 RNA dependent RNA polymerase Suliman Khan, Farnoosh Attar, Samir Haj Bloukh, Majid Sharifi, Faisal Nabi, Qian Bai, et al. (+2)
48 [GO] 2021―Mar―12 Exploitation of polyphenols and proteins using nanoencapsulation for anti-viral and brain boosting properties - Evoking a synergistic strategy to combat COVID-19 pandemic Nairah Noor, Adil Gani, Asir Gani, Asima Shah, Zanoor ul Ashraf
49 [GO] 2021―Mar―02 The human pandemic coronaviruses on the show: The spike glycoprotein as the main actor in the coronaviruses play Pedro F.N. Souza, Felipe P. Mesquita, Jackson L. Amaral, Patrícia G.C. Landim, Karollyny R.P. Lima, Marília B. Costa, et al. (+3)
50 [GO] 2021―Mar―01 SARS-CoV-2: Insights into its structural intricacies and functional aspects for drug and vaccine development Mandeep Kaur, Akanksha Sharma, Santosh Kumar, Gurpal Singh, Ravi P. Barnwal
51 [GO] 2021―Feb―17 Underscoring the immense potential of chitosan in fighting a wide spectrum of viruses: A plausible molecule against SARS-CoV-2? Nivya Sharma, Chandrima Modak, Pankaj Kumar Singh, Rahul Kumar, Dharmender Khatri, Shashi Bala Singh
52 [GO] 2021―Feb―11 COVID-19 as a worldwide selective event and bitter taste receptor polymorphisms: An ecological correlational study Shima Parsa, Vahid Mogharab, Mohsen Ebrahimi, Sayyed Reza Ahmadi, Behzad Shahi, Neema John Mehramiz, et al. (+7)
53 [GO] 2021―Feb―09 Potential drug targets of SARS-CoV-2: From genomics to therapeutics Anas Shamsi, Taj Mohammad, Saleha Anwar, Samreen Amani, Mohd Shahnawaz Khan, Fohad Mabood Husain, et al. (+3)
54 [GO] 2021―Feb―05 Epigallocatechin-3-gallate, an active ingredient of Traditional Chinese Medicines, inhibits the 3CLpro activity of SARS-CoV-2 Ashuai Du, Rong Zheng, Cyrollah Disoma, Shiqin Li, Zongpeng Chen, Sijia Li, et al. (+18)
55 [GO] 2021―Feb―05 Targeting C-terminal Helical bundle of NCOVID19 Envelope (E) protein Shruti Mukherjee, Amaravadhi Harikishore, Anirban Bhunia
56 [GO] 2021―Jan―11 SARS-Cov-2 ORF3a: Mutability and function Martina Bianchi, Alessandra Borsetti, Massimo Ciccozzi, Stefano Pascarella
57 [GO] 2020―Dec―29 Development of new vaccine target against SARS-CoV2 using envelope (E) protein: An evolutionary, molecular modeling and docking based study Shreya Bhattacharya, Arundhati Banerjee, Sujay Ray
58 [GO] 2020―Dec―09 Ritonavir may inhibit exoribonuclease activity of nsp14 from the SARS-CoV-2 virus and potentiate the activity of chain terminating drugs Naveen Narayanan, Deepak T. Nair
59 [GO] 2020―Dec―06 Assessment of antiviral potencies of cannabinoids against SARS-CoV-2 using computational and in vitro approaches Vinit Raj, Jae Gyu Park, Kiu-Hyung Cho, Pilju Choi, Taejung Kim, Jungyeob Ham, Jintae Lee
60 [GO] 2020―Sep―28 Novel insights into the treatment of SARS-CoV-2 infection: An overview of current clinical trials Fatemeh Oroojalian, Ali Haghbin, Behzad Baradaran, Nima Hemmat, Mohammad-Ali Shahbazi, Hossein Bannazadeh Baghi, et al. (+2)
61 [GO] 2020―Sep―24 Evaluation of the potency of FDA-approved drugs on wild type and mutant SARS-CoV-2 helicase (Nsp13) Osman Mutluhan Ugurel, Ozal Mutlu, Emrah Sariyer, Sinem Kocer, Erennur Ugurel, Tugba Gul Inci, et al. (+2)
62 [GO] 2020―Sep―24 The structure-activity relationship of the interactions of SARS-CoV-2 spike glycoproteins with glucuronomannan and sulfated galactofucan from Saccharina japonica Weihua Jin, Wenjing Zhang, Dipanwita Mitra, Martin G. McCandless, Poonam Sharma, Ritesh Tandon, et al. (+2)
63 [GO] 2020―Sep―17 Prediction of potential inhibitors for RNA-dependent RNA polymerase of SARS-CoV-2 using comprehensive drug repurposing and molecular docking approach Md. Sorwer Alam Parvez, Md. Adnan Karim, Mahmudul Hasan, Jomana Jaman, Ziaul Karim, Tohura Tahsin, et al. (+2)
64 [GO] 2020―Aug―24 Screening and evaluation of approved drugs as inhibitors of main protease of SARS-CoV-2 Praveen Kumar Tripathi, Saurabh Upadhyay, Manju Singh, Siva Raghavendhar, Mohit Bhardwaj, Pradeep Sharma, Ashok Kumar Patel
65 [GO] 2020―Aug―01 Structural stability of SARS-CoV-2 3CLpro and identification of quercetin as an inhibitor by experimental screening Olga Abian, David Ortega-Alarcon, Ana Jimenez-Alesanco, Laura Ceballos-Laita, Sonia Vega, Hugh T. Reyburn, et al. (+2)
66 [GO] 2020―Jul―18 A molecular docking study revealed that synthetic peptides induced conformational changes in the structure of SARS-CoV-2 spike glycoprotein, disrupting the interaction with human ACE2 receptor Pedro F.N. Souza, Francisco E.S. Lopes, Jackson L. Amaral, Cleverson D.T. Freitas, Jose T.A. Oliveira
67 [GO] 2020―Jul―15 Design of a Multi-epitope Vaccine against SARS-CoV-2 using Immunoinformatics approach Samira Sanami, Milad Zandi, Behzad Pourhossein, Gholam-Reza Mobini, Mohsen Safaei, Atena Abed, et al. (+3)
68 [GO] 2020―Jul―14 Application prospect of polysaccharides in the development of anti-novel coronavirus drugs and vaccines Xiangyan Chen, Wenwei Han, Guixiang Wang, Xia Zhao
69 [GO] 2020―Jun―26 Targeting hub genes and pathways of innate immune response in COVID-19: A network biology perspective Kartikay Prasad, Fatima Khatoon, Summya Rashid, Nemat Ali, Abdullah F. AlAsmari, Mohammad Z. Ahmed, et al. (+3)
70 [GO] 2020―Jun―26 Designing a novel mRNA vaccine against SARS-CoV-2: An immunoinformatics approach Ishtiaque Ahammad, Samia Sultana Lira
71 [GO] 2020―May―30 A recombinant Lactobacillus plantarum strain expressing the spike protein of SARS-CoV-2 Maopeng Wang, Tingting Fu, Jiayi Hao, Letian Li, Mingyao Tian, Ningyi Jin, et al. (+2)
72 [GO] 2020―May―26 High throughput virtual screening reveals SARS-CoV-2 multi-target binding natural compounds to lead instant therapy for COVID-19 treatment Biswajit Naik, Nidhi Gupta, Rupal Ojha, Satyendra Singh, Vijay Kumar Prajapati, Dhaneswar Prusty
73 [GO] 2019―Dec―02 Construction and optimization of Lactobacillus plantarum expression system expressing glycoprotein 5 of porcine reproductive and respiratory syndrome virus Maopeng Wang, Shouwen Du, Wang Xu, Lina Song, Pengfei Hao, Ningyi Jin, et al. (+2)
 [1] 

73 Results       Page 1



[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.007 sec